Ischemic Stroke, Acute: Clinical Trials

19 trials for Ischemic Stroke, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 6 completed, 5 unknown, 1 not yet recruiting. 19 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 319Recruiting 7, Completed 6, Unknown 5, Not yet recruiting 1
Phase 24Unknown 3, Recruiting 1

Follow Ischemic Stroke, Acute: new trials by email Literature Review of Ischemic Stroke, Acute trials Research Report on Ischemic Stroke, Acute

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
Recombinant Tissue Plasminogen Activator (rt-PA), Intra-arterial Thrombolysis, Best Medical Management - Medium Vessel Occlusion, Ischemic Stroke, Acute
Phase 3RecruitingThe First Affiliated Hospital with Nanjing Medical University3722026-09-192026-09-23
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
non-immunogenic staphylokinase, Placebo - Ischemic Stroke, Acute
Phase 3RecruitingSupergene, LLC10502026-06-092026-11-12
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke
Remote Ischemic Conditioning, Sham Remote Ischemic Conditioning - Ischemic Stroke, Acute, Myocardial Injury
Phase 3Not yet recruitingCapital Medical University5802026-05-012026-04-15
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
Tegoprazan 50 mg, Placebo - Ischemic Stroke, Ischemic Stroke, Acute
Phase 3RecruitingHanyang University Guri Hospital15242026-01-262026-07-08
Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke
Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownCapital Medical University3022024-11-202024-10-29
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )
Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit - Ischemic Stroke, Acute
Phase 3UnknownBeijing Tiantan Hospital6002024-08-102024-10-01
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-C )
Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit adherent to guidelines - Ischemic Stroke, Acute
Phase 3CompletedBeijing Tiantan Hospital16222024-08-082025-08-22
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
Tirofiban, Placebo - Ischemic Stroke, Acute, TIA
Phase 3RecruitingBeijing Tiantan Hospital46742024-07-112024-07-12
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
Intra-arterial tenecteplase injection at the completion of thrombectomy, Placebo - Ischemic Stroke, Acute, Cerebrovascular Disorders
Phase 2 / Phase 3RecruitingUniversity of Melbourne4622024-06-012026-05-18
Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke
Early Dual Antiplatelet Therapy, Placebo - Ischemic Stroke, Acute
Phase 3CompletedBeijing Tiantan Hospital13822024-04-032026-01-22
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Tenecteplase, direct EVT - Ischemic Stroke, Acute, Thrombolysis
Phase 3CompletedBeijing Tiantan Hospital3912024-01-252025-11-26
Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
Tenecteplase, Best Practice (which may include intravenous Alteplase) - Ischemic Stroke, Acute
Phase 3CompletedBeijing Tiantan Hospital4522024-01-242025-11-26
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Shuxuening Injection, Placebo - Ischemic Stroke, Acute
Phase 3RecruitingBeijing Tiantan Hospital13802024-01-112025-07-24
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
Edaravone Dexborneol Concentrated Solution for injection, Edaravone Dexborneol placebo - Ischemic Stroke, Acute, Treatment Outcome
Phase 3UnknownXiangya Hospital of Central South University2122023-07-012023-06-27
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
Minocycline hydrochloride capsule, Placebo capsules of Minocycline hydrochloride capsules - Ischemic Stroke, Acute
Phase 3CompletedBeijing Tiantan Hospital17242023-05-192025-05-14
Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS)
Yiqihuayu Decotion - Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownYing Gao152022-09-252022-09-29
Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
Intravenous tenecteplase, Placebo - Ischemic Stroke, Acute
Phase 3RecruitingHospital Moinhos de Vento4662022-01-202025-04-04
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
tenecteplase (0.25 mg/kg, Max 25 mg), standard medical treatment - Ischemic Stroke, Acute
Phase 3CompletedBeijing Tiantan Hospital5162022-01-192024-04-30
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
Ginkgo diterpene lactone meglumine injection, Ginkgo diterpene lactone meglumine injection simulation, Aspirin - Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownShanghai Yueyang Integrated Medicine Hospital802021-01-012022-12-29

Narrower conditions

Ischemic Stroke (19)  ·  Cerebrovascular Disorders (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Infarction (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Infarction, Middle Cerebral Artery (1)  ·  Ischemic Attack, Transient (1)  ·  Stroke (1)  ·  cyclopia sequence (1)

Broader conditions

Cardiovascular Diseases (19)  ·  Nervous System Diseases (19)  ·  Vascular Diseases (19)  ·  Brain Diseases (18)  ·  Central Nervous System Diseases (18)  ·  Stroke (18)  ·  Cerebrovascular Disorders (17)  ·  Brain Ischemia (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Brain Infarction (2)  ·  Infarction (2)  ·  Ischemia (2)  ·  Necrosis (2)  ·  Cerebral Arterial Diseases (1)

Interventions

Tenecteplase (5)  ·  Aspirin (3)  ·  Tirofiban (2)  ·  Clopidogrel (1)  ·  Injections (1)  ·  MAX protein, human (1)  ·  Minocycline (1)  ·  Practice Guidelines as Topic (1)  ·  TNK-tissue plasminogen activator (1)  ·  Ticagrelor (1)  ·  Tissue Plasminogen Activator (1)  ·  shuxuening (1)  ·  tegoprazan (1)

Sponsors

Beijing Tiantan Hospital (9)  ·  Capital Medical University (2)  ·  Hanyang University Guri Hospital (1)  ·  Hospital Moinhos de Vento (1)  ·  Shanghai Yueyang Integrated Medicine Hospital (1)  ·  Supergene, LLC (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  University of Melbourne (1)  ·  Xiangya Hospital of Central South University (1)  ·  Ying Gao (1)

Countries

China (13)  ·  Australia (1)  ·  Brazil (1)  ·  New Zealand (1)  ·  Russia (1)  ·  South Korea (1)

Top investigators

Yongjun Wang (2)  ·  Bruce Campbell, MD, PhD (1)  ·  Fana Alemseged, MD, PhD (1)  ·  Fengyuan Che, MD (1)  ·  Gisele Sampaio Silva, MD, MPH, PhD (1)  ·  Nikolay A. Shamalov, MD, prof (1)  ·  Raul G Nogueira, MD (1)  ·  Sergey S. Markin, MD, prof (1)  ·  Sheila CO Martins, MD, PhD (1)  ·  Sheng Liu, Professor (1)  ·  Yan Han, Ph.D. (1)  ·  Yilong Wang, MD, PhD (1)  ·  Yilong Wang, PhD+MD (1)  ·  Yongjun Wang, MD (1)  ·  Yongjun Wang, MD, PhD (1)

Results publications

PMID 34487721, PMID 11306611, PMID 19628804, PMID 21737808, PMID 21909339, PMID 22632907, PMID 25888869, PMID 26510778, PMID 27673305, PMID 29232823, PMID 29444972, PMID 29601945, PMID 29948247, PMID 30619060, PMID 31263257, PMID 31296369, PMID 31570084, PMID 31610199, PMID 31719236, PMID 31899551, PMID 32374815, PMID 33077917, PMID 33588596, PMID 33879319, PMID 34224187, PMID 34418399, PMID 35233540, PMID 35461991, PMID 36239644, PMID 37247876, PMID 37256974, PMID 38648030, PMID 38884324, PMID 41151803, PMID 41293810, PMID 41611343, PMID 41628627, PMID 41655588, PMID 41815809, PMID 41992212, PMID 42099212, PMID 42114550, PMID 42159994, PMID 42689322